JWS Consulting is a division of Johnson Winter & Slattery providing commercial consulting services.
We are engaged by major Australian and international corporations as legal counsel on their business activities, disputes and most challenging matters.
Established in 1993 by Tony Johnson, Nigel Winter and Peter Slattery as a boutique corporate firm, JWS grew rapidly to become a leading independent Australian firm.
The quality of our legal advice and service to clients is recognised through independent industry recognition and direct client feedback.
Learn more about breaking news at Johnson Winter & Slattery, including major transaction announcements, practitioner appointments and team expansions.
JWS supports a number of community initiatives and not for profit organisations across Australia through pro bono legal work, charitable donations and sponsorships.
In 2018, we celebrated 25 years of long-lasting relationships with our valued clients.
Andrew is a corporate lawyer specialising in mergers and acquisitions and private equity.
He has extensive experience in negotiated mergers and acquisitions, foreign investment, cross-border transactions, joint ventures, private equity, commercial transactions and corporate law.
Andrew has taken a lead role in numerous commercial transactions, particularly in the negotiated M&A and FMCG spaces. He has been repeatedly recognised as a leading Mergers & Acquisitions lawyer by Best Lawyers Australia.
Acting for Unilever on:
its acquisitions of Weis Frozen Foods and T2 Tea
the sale of brands including Raguletto and Chicken Tonight.
Acting for Gazal on its recent sales of Bisley Workwear and Trade Secret businesses.
Acting for Tyrrells on its acquisition of Yarra Valley Snack Foods.
Acting for Arrium on the sale of its sheet and coil business to BlueScope.
Acting for USS on various acquisitions, including Sydney Airport Link and Brisbane Airtrain.
Acting for Zoetis on the Australian aspects of its acquisition of Nexvet Biopharma plc.
Acting for Ruralco on a series of acquisitions and joint ventures.
Acting on a series of business acquisitions in Australia.
Acting for SK Capital on its acquisition of Tasmanian Alkaloids.
Acting for CDC and its shareholders in their partial divestment to Quadrant Private Equity.
Advising in relation to Archer’s secondary buy-out of LCR Group from CHAMP Private Equity; Archer’s secondary buy-out of Aero-Care from Next Capital; and Archer’s acquisition of Dun & Bradstreet.
Acting on the sale of a private equity funds business.
Assisting the management team in relation to participation in the IPO of MYOB.
Advising in relation to commercial transactions.
Listed as a leading lawyer in Mergers & Acquisitions
Recommended in Corporate / M&A
Securities and Investments Law and Taxation Law
Deal Maker of the Year 'Unilever acquisition of T2'